Dave has now been given a prognosis of six to 12 months. His wife Samantha is desperately trying to raise £60,000 to help ...
A mum is in a desperate race to raise £60,000 to buy her husband more time with their young sons after what first appeared to ...
HK inno.N's K-CAB met primary endpoints in a 783-patient U.S. Phase 3 trial, improving heartburn and acid reflux versus placebo.
VOQUEZNA (vonoprazan) is a potassium-competitive acid blocker (PCAB) that reduces stomach acid production. It is approved in the U.S. for adults with erosive GERD, heartburn associated with ...
The US Food and Drug Administration (FDA) approved Hovilpri (pritelivir) tablets for adults with weakened immune systems (i.e ...
New analysis projects VOQUEZNA® (vonoprazan) to provide meaningful economic value and be cost-effective vs. proton pump inhibitors (PPIs) for ...
Detailed analysis from the randomized, double-blind, placebo-controlled Phase 3 TRIUMpH-NERD study demonstrated that both ...
A family friend is suddenly on hospice care because of esophageal cancer, which has spread to his lungs and liver. The thing ...
Three scientific presentations will highlight new analyses of VOQUEZNA® (vonoprazan) in GERD, including real-world patient characteristics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results